For nearly four decades, the Belgian Charcot Foundation has supported cutting-edge research on multiple sclerosis (MS) in Belgium with one clear ambition: to deepen our understanding of the disease, accelerate the development of treatments, and improve the quality of life for those affected.
Today, the Foundation begins a new chapter with the appointment of Professor Bénédicte Dubois as its new President.
An internationally recognized neurologist specializing in MS, Professor Dubois leads the neurology department at UZ Leuven and heads the neuro-immunology research group at KU Leuven. Her work focuses on the immunological and genetic mechanisms of MS, with a strong emphasis on precision medicine. She brings to the role a deep scientific expertise and a vision shaped by decades of interdisciplinary research.
She succeeds Emeritus Professor Christian Sindic, who has served as President for the past ten years. Under his leadership, the Foundation expanded its support for scientific research and established itself as a trusted institution in the field of neurology. We are deeply grateful for his unwavering dedication, intellectual integrity, and strategic vision, which have led to numerous scientific advances.
Building on this legacy, Professor Dubois is committed to strengthening the Foundation’s role as a bridge between science, patients, and the broader public. One of her first initiatives is the development of a new digital knowledge center on MS—a reliable, accessible platform for patients, families, and healthcare professionals. The content, based on Professor Sindic’s years of work, is being refined and brought to life through close collaboration with the new President. It stands as a powerful symbol of continuity, scientific excellence, and public engagement.
In parallel, the Foundation will expand its presence on social media to share trustworthy, up-to-date information more widely. Professor Dubois also aims to foster closer collaboration among research teams across Belgian universities, strengthening national networks and encouraging innovative joint projects.
The Charcot Fund will remain at the heart of this effort—an essential catalyst that empowers Belgian researchers to pursue promising and often life-changing studies. Professor Dubois takes pride in continuing this mission with energy and focus.
None of this would be possible without the generosity of the Foundation’s supporters. Our donors are true partners in advancing science. Thanks to their continued trust, concrete progress is being made for the benefit of people living with MS.
With a spirit of openness, scientific rigor, and a commitment to patients, this new presidency sets a hopeful course for the years ahead. Professor Dubois brings to this role not only her remarkable expertise but also a deep commitment to translating scientific knowledge into meaningful impact.
